Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.

MLA

Azmandian, Jalal, et al. “Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.” American Journal of Nephrology, vol. 48, no. 4, 2018, pp. 251–59. EBSCOhost, https://doi.org/10.1159/000493097.

APA

Azmandian, J., Abbasi, M. R., Pourfarziani, V., Nasiri, A. A., Ossareh, S., Ezzatzadegan Jahromi, S., Sanadgol, H., Amini, S., & Shahvaroughi Farahani, A. (2018). Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients. American Journal of Nephrology, 48(4), 251–259. https://doi.org/10.1159/000493097

Chicago

Azmandian, Jalal, Mohammad Reza Abbasi, Vahid Pourfarziani, Amir Ahmad Nasiri, Shahrzad Ossareh, Shahrokh Ezzatzadegan Jahromi, Hooshang Sanadgol, Somayeh Amini, and Arshia Shahvaroughi Farahani. 2018. “Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.” American Journal of Nephrology 48 (4): 251–59. doi:10.1159/000493097.